tradingkey.logo
搜索

Vyne Therapeutics Inc

VYNE
添加自选
28.560USD
0.0000.00%
收盘 07-27 16:00美东报价延迟15分钟
18.71M总市值
亏损市盈率 TTM

VYNE 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Vyne Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Vyne Therapeutics Inc财报日历

最新发布
5月 15, 2026
每股收益 / 预测值
-0.08/-0.18
营业收入 / 预测值
86.00K/200.00K
报告期
FY2025 财报
营业收入(YoY)
570.00K
13.77%
每股收益(YoY)
-0.62
33.80%
分析师评级
2026/07/31
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
58.46%-0.08
60.01%-0.11
40.42%-0.17
39.06%-0.13
-37.50%-0.20
-42.72%-0.28
85.77%-0.29
92.81%-0.22
91.50%-0.15
93.59%-0.20
---2.01
---3.07
---1.73
---3.08
---4.18
----
----
----
----
----
营业收入
-57.43%86.00K
54.76%130.00K
39.67%169.00K
-65.15%69.00K
106.12%202.00K
10.53%84.00K
6.14%121.00K
46.67%198.00K
-1.01%98.00K
1166.67%76.00K
-31.74%114.00K
7.14%135.00K
-44.38%99.00K
-99.74%6.00K
-95.91%167.00K
-57.29%126.00K
-22.61%178.00K
-46.52%2.29M
24.99%4.09M
-97.48%295.00K
净利润
58.37%-3.58M
59.77%-4.84M
40.12%-7.28M
38.82%-5.75M
-37.80%-8.61M
-94.28%-12.02M
-84.64%-12.16M
6.48%-9.41M
-11.15%-6.25M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
14.04%-9.95M
55.56%-9.46M
57.46%-8.48M
122.73%4.67M
50.09%-11.57M
13.87%-21.29M
88.10%-19.92M
利润率
2.12%-4168.60%
73.32%-3815.38%
56.27%-4394.08%
-75.53%-8328.99%
33.12%-4258.91%
-76.69%-14302.38%
-88.66%-10047.11%
36.19%-4744.95%
-12.34%-6368.37%
93.74%-8094.74%
---5325.44%
---7435.56%
---5668.69%
---129350.00%
---5559.24%
----
----
----
----
----
毛利率
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
资产负债率
----
----
----
----
----
----
----
----
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
营业收入
-57.43%86.00K
54.76%130.00K
39.67%169.00K
-65.15%69.00K
106.12%202.00K
10.53%84.00K
6.14%121.00K
46.67%198.00K
-1.01%98.00K
1166.67%76.00K
-31.74%114.00K
7.14%135.00K
-44.38%99.00K
-99.74%6.00K
-95.91%167.00K
-57.29%126.00K
-22.61%178.00K
-46.52%2.29M
24.99%4.09M
-97.48%295.00K
营业利润
58.51%-3.82M
59.13%-5.22M
40.48%-7.79M
27.45%-7.54M
-24.62%-9.20M
-86.91%-12.77M
-109.99%-13.09M
-0.76%-10.40M
-25.62%-7.38M
14.43%-6.83M
33.20%-6.23M
-24.51%-10.32M
32.40%-5.88M
33.71%-7.98M
47.50%-9.33M
13.15%-8.29M
10.93%-8.69M
45.23%-12.04M
24.33%-17.78M
94.29%-9.54M
净利润
58.37%-3.58M
59.77%-4.84M
40.12%-7.28M
38.82%-5.75M
-37.80%-8.61M
-94.28%-12.02M
-84.64%-12.16M
6.48%-9.41M
-11.15%-6.25M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
14.04%-9.95M
55.56%-9.46M
57.46%-8.48M
122.73%4.67M
50.09%-11.57M
13.87%-21.29M
88.10%-19.92M
流动资产
-53.04%25.79M
-53.43%30.01M
-51.20%35.89M
-47.07%44.34M
-39.14%54.91M
-32.85%64.44M
319.94%73.53M
264.89%83.78M
173.22%90.22M
150.72%95.96M
-60.24%17.51M
-55.78%22.96M
-45.56%33.02M
-39.42%38.27M
-42.14%44.05M
-59.57%51.92M
-57.62%60.65M
-27.59%63.19M
-22.45%76.13M
7.66%128.43M
流动负债总额
-89.94%1.24M
-83.84%2.40M
-68.06%4.04M
-50.35%5.84M
77.36%12.29M
96.59%14.82M
96.33%12.66M
84.41%11.75M
-7.83%6.93M
-19.34%7.54M
-5.70%6.45M
-6.74%6.37M
-12.45%7.52M
-49.24%9.35M
-67.43%6.84M
-88.14%6.83M
-60.15%8.59M
-15.41%18.41M
-9.46%21.00M
137.78%57.62M
总资产
-54.14%25.87M
-54.92%30.16M
-52.58%36.13M
-48.39%44.72M
-38.45%56.42M
-31.51%66.91M
295.48%76.20M
247.16%86.65M
159.98%91.68M
139.67%97.69M
-58.93%19.27M
-54.78%24.96M
-45.17%35.26M
-39.21%40.76M
-42.31%46.91M
-58.81%55.19M
-56.88%64.32M
-28.48%67.05M
-24.49%81.31M
2.40%133.98M
总负债
-89.94%1.24M
-83.84%2.40M
-68.06%4.04M
-50.45%5.84M
47.98%12.29M
65.58%14.82M
63.12%12.66M
53.23%11.78M
-5.96%8.31M
-4.23%8.95M
13.50%7.76M
12.47%7.69M
2.84%8.83M
-49.24%9.35M
-69.51%6.84M
-88.43%6.83M
-84.74%8.59M
-67.27%18.41M
-61.44%22.43M
-0.38%59.09M
总权益
-44.17%24.64M
-46.69%27.77M
-49.50%32.09M
-48.07%38.88M
-47.06%44.13M
-41.30%52.09M
452.26%63.54M
333.47%74.87M
215.43%83.37M
182.48%88.73M
-71.29%11.51M
-64.28%17.27M
-52.57%26.43M
-35.41%31.41M
-31.95%40.07M
-35.43%48.36M
-40.01%55.73M
29.72%48.64M
18.92%58.89M
4.70%74.89M
经营净额
64.39%-4.08M
58.17%-3.76M
16.62%-7.10M
-27.38%-10.80M
-43.59%-11.46M
-75.18%-9.00M
-65.18%-8.51M
11.42%-8.48M
-45.71%-7.98M
-32.57%-5.14M
16.76%-5.15M
-16.40%-9.57M
39.40%-5.48M
61.32%-3.88M
64.72%-6.19M
49.41%-8.22M
27.98%-9.04M
60.52%-10.02M
25.79%-17.54M
54.66%-16.26M
投资净额
-76.30%4.70M
-33.58%8.46M
191.25%4.40M
-75.42%4.67M
655.65%19.83M
120.43%12.74M
---4.82M
--19.02M
-171.38%-3.57M
-6568.88%-62.35M
100.00%0.00
--0.00
-68.26%5.00M
---935.00K
---1.02M
-100.00%0.00
--15.75M
-100.00%0.00
--0.00
-95.14%1.03M
融资净额
82.76%-15.00K
88.64%-15.00K
-250.00%-7.00K
-1033.33%-34.00K
-2075.00%-87.00K
-100.16%-132.00K
95.74%-2.00K
40.00%-3.00K
98.16%-4.00K
39641.83%82.66M
-80.77%-47.00K
91.80%-5.00K
-114.16%-217.00K
647.37%208.00K
99.92%-26.00K
52.71%-61.00K
-97.92%1.53M
-100.48%-38.00K
-41025.61%-33.56M
-100.24%-129.00K

常见问题

Vyne Therapeutics Inc的总收入是多少?

根据Vyne Therapeutics Inc的FY2025财报,总收入达到了570.00K(同比变化501.00K)。

Vyne Therapeutics Inc的流动资产是多少?

根据Vyne Therapeutics Inc的FY2025财报,流动资产为30.01M(同比变化-53.43)。

Vyne Therapeutics Inc的总资产是多少?

根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的总资产为30.16M(同比变化-54.92)。

Vyne Therapeutics Inc的总负债是多少?

根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的总负债为2.40M(同比变化-83.84)。

Vyne Therapeutics Inc的总权益是多少?

根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的总权益为27.77M(同比变化-46.69)。

Vyne Therapeutics Inc的净营业收入是多少?

根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的净营业收入为-29.75M(同比变化31.83)。

Vyne Therapeutics Inc的净投资是多少?

根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的净投资为37.37M(同比变化59.93)。

Vyne Therapeutics Inc的净融资是多少?

根据Vyne Therapeutics Inc的FY2025财报,Vyne Therapeutics Inc的净融资为-143.00K(同比变化-1.42)。

Vyne Therapeutics Inc的每股收益(EPS)是多少?

根据Vyne Therapeutics Inc的FY2025财报,每股收益(EPS)为-0.62(同比变化33.80)。

Vyne Therapeutics Inc的净利润是多少?

根据Vyne Therapeutics Inc的FY2025财报,净利润为-26.48M(同比变化33.52)。

Vyne Therapeutics Inc的净利润率是多少?

根据Vyne Therapeutics Inc的FY2025财报,净利润率为-4690.53(同比变化40.97)。

Vyne Therapeutics Inc的股东权益回报率(ROE)是多少?

根据Vyne Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-66.96(同比变化-18.45)。

Vyne Therapeutics Inc的资产回报率(ROA)是多少?

根据Vyne Therapeutics Inc的FY2025财报,资产回报率(ROA)为-55.09(同比变化-13.89)。

Vyne Therapeutics Inc的营业利润是多少?

根据Vyne Therapeutics Inc的FY2025财报,营业利润为-29.75M(同比变化31.83)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有